VASCULAR BIOGENICS LTD shareholders Q2 2023

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 17 filers reported holding VASCULAR BIOGENICS LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

VASCULAR BIOGENICS LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Spectrum Planning & Advisory Services Inc. 16,000$4,1570.01%
CATALYST FINANCIAL PARTNERS LLC 39,000$8,9700.00%
Virtu Financial LLC 79,892$180.00%
MORGAN STANLEY 327,011$75,2130.00%
HBK Sorce Advisory LLC 20,575$4,7330.00%
Harel Insurance Investments & Financial Services Ltd. 11,000$30.00%
HRT FINANCIAL LP 13,526$30.00%
Tower Research Capital LLC (TRC) 937$2160.00%
ROYAL BANK OF CANADA 798$00.00%
NewEdge Advisors, LLC 1,700$3910.00%
BNP PARIBAS FINANCIAL MARKETS 100$230.00%
TWO SIGMA INVESTMENTS, LP 32,900$7,5670.00%
OSAIC HOLDINGS, INC. 22,491$5,2000.00%
BANK OF AMERICA CORP /DE/ 8,192$1,8840.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 127,293$29,2770.00%
GEODE CAPITAL MANAGEMENT, LLC 40,323$9,2740.00%
External links

This page lists VASCULAR BIOGENICS LTD's shareholders in Q2 2023. To view VASCULAR BIOGENICS LTD's shareholder history, click here.